Kim, Helena
Ali, Rafia
Short, Samuel
Kaunfer, Sarah http://orcid.org/0000-0003-3335-1408
Krishnamurthy, Shobana
Durai, Lavanya http://orcid.org/0009-0005-6547-2564
Yilmam, Osman http://orcid.org/0000-0001-8202-1320
Shenoy, Tushar http://orcid.org/0000-0002-5660-6111
Monson, Audrey E. http://orcid.org/0009-0003-9287-9680
Thomas, Charlotte http://orcid.org/0000-0002-5602-0890
Park, Isabel
Martini, Dylan
Newcomb, Richard
Shapiro, Roman M.
Soiffer, Robert J. http://orcid.org/0000-0002-5810-1192
DeFilipp, Zachariah http://orcid.org/0000-0002-7994-8974
Baron, Rebecca M.
Gupta, Shruti
Sise, Meghan E. http://orcid.org/0000-0002-4327-9713
Leaf, David E. http://orcid.org/0000-0001-7875-090X
Article History
Received: 28 June 2023
Revised: 10 October 2023
Accepted: 17 October 2023
First Online: 7 November 2023
Competing interests
: The authors report no competing financial interests in relation to this work. DEL received research support from BioPorto, BTG International, and Metro International Biotech LLC, and has received consulting fees from Sidereal Therapeutics, Casma Therapeutics, and MexBrain. RJS has received consulting fees from Vor Biopharma, Smart Immune, Daiichi Sankyo Inc., Neovii, CSL Behring, Bluesphere Bio, Cugene, Jasper, Takeda, Jazz Pharmaceuticals, Precision Biosciences, Alexion, and Rheos Therapeutics. RMB served on advisory boards for Genentech and Merck. SG received research support from BTG International, GE Healthcare, and AstraZeneca, is a member of GlaxoSmithKline’s Global Anemia Council, a consultant for Secretome and Proletariat Therapeutics, and founder of the American Society of Onconephrology.